Macrophage-targeted emodin nanomaterials for effective acute pancreatitis treatment via modulation of the JNK pathway

We developed a heparin-modified emodin carrier (HEZ) that targets inflamed pancreatic tissue via CD44-mediated macrophage activation. HEZ restored mitochondrial function and reduced oxidative stress by blocking the JNK pathway.